Dominique Figarella‐Branger

Author

Also Known As

Anja zur Mühlen, Caroline Dehais, Claude-Alain Maurage, D F Figarella-Branger, D Figarella-Branger, D Figarella‐Branger, D Meyronet, D. FIGARELLA‐BRANGER, D. Figarella-Branger, D. Figarella-branger

880

Publications

37.3K

Citations

H-Index

233

Concepts

All Affiliations

Hôpital de la Timone Inserm Centre National de la Recherche Scientifique Aix-Marseille Université Assistance Publique Hôpitaux de Marseille

About

Dominique Figarella‐Branger is an author at Hôpital de la Timone specializing in medicine, pathology, and neuro-oncology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	57	150	10.1K
2	Health Sciences	22	30	2.2K
3	Engineering	5	5	940
4	Public Health	2	2	24
5	Natural Sciences	1	1	141

Dominique Figarella‐Branger

317

Publications

21.8K

Citations

H-Index

Page 1

	Year	Citations
New Brain Tumor Entities Emerge from Molecular Classification of CNS-PNETs Dominik Sturm, Brent A. Orr, Umut H. Toprak, Cell Neuro-oncologyMolecular ClassificationCerebral OrganoidNeurologyNeuroscience	2016	973
<scp>I</scp>nternational <scp>S</scp>ociety of <scp>N</scp>europathology‐<scp>H</scp>aarlem <scp>C</scp>onsensus <scp>G</scp>uidelines for <scp>N</scp>ervous <scp>S</scp>ystem <scp>T</scp>umor <scp>C</scp>lassification and <scp>G</scp>rading David N. Louis, Arie Perry, Peter C. Burger, Brain Pathology Tumor EntityNeuro-oncologyDisease DiagnosisEngineeringMedicine	2014	561
cIMPACT‐NOW update 6: new entity and diagnostic principle recommendations of the cIMPACT‐Utrecht meeting on future CNS tumor classification and grading David N. Louis, Pieter Wesseling, Kenneth Aldape, Brain Pathology Oncologic ImagingPathologyGliomaCns Tumor ClassificationTumor Biology	2020	514
Hyperfractionated Versus Conventional Radiotherapy Followed by Chemotherapy in Standard-Risk Medulloblastoma: Results From the Randomized Multicenter HIT-SIOP PNET 4 Trial Birgitta Lannering, Stefan Rutkowski, François Doz, Journal of Clinical Oncology	2012	321
Histopathological grading of pediatric ependymoma: reproducibility and clinical relevance in European trial cohorts David W. Ellison, Mehmet Koçak, Dominique Figarella‐Branger, Journal of Negative Results in BioMedicine	2011	303
Absence of IDH mutation identifies a novel radiologic and molecular subtype of WHO grade II gliomas with dismal prognosis Philippe Métellus, Béma Coulibaly, Carole Colin, Acta Neuropathologica Neuro-oncologySomatic VariantTumor HeterogeneityMedicineBrain Tumor Biology	2010	286
CDKN2A homozygous deletion is a strong adverse prognosis factor in diffuse malignant IDH-mutant gliomas Romain Appay, Caroline Dehais, Claude‐Alain Maurage, Neuro-Oncology	2019	276
Pilocytic Astrocytomas in Children: Prognostic Factors—A Retrospective Study of 80 Cases Carla Fernandez, Dominique Figarella‐Branger, Nadine Girard, Neurosurgery	2003	266
Phenotypic Study in 40 Patients With Dysferlin Gene Mutations Karine Nguyen, Guillaume Bassez, Martin Krahn, Archives of Neurology	2007	262
Macrophagic myofasciitis: an emerging entity RK Gherardi, M Coquet, P. Chérin, The Lancet Autoimmune DiseasePathogenesisHistopathologyImmunologyInfection Control	1998	240

Page 1